X

Trial Profile

Phase I Clinical and Pharmacokinetic Study of Pazopanib in a Population of Frail Elderly Patients According SIOG Criteria

Status: Discontinued

Phase of Trial: Phase I

Latest Information Update: 07 Sep 2023

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Pazopanib (Primary)
Indications Advanced breast cancer; Bladder cancer; Neuroendocrine carcinoma; Non-small cell lung cancer; Ovarian cancer; Pancreatic cancer; Renal cancer; Sarcoma; Thyroid cancer
Focus Adverse reactions
Acronyms VOTRAGE

Most Recent Events

03 Aug 2018 Status changed from active, no longer recruiting to discontinued due to slow recruitment rate
12 Feb 2018 Planned End Date changed from 1 Dec 2016 to 1 May 2019.
12 Feb 2018 Planned primary completion date changed from 1 Oct 2015 to 1 May 2019.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com